Content Validation of the Movement Disorder-Childhood Rating Scale (MD-CRS) for Dyskinetic Cerebral Palsy

Daniel O Claassen1, Heather R Riordan1, Leon S Dure2

  • 1Vanderbilt University Medical Center, Nashville, Tennessee.

Pediatric Neurology
|February 12, 2023
PubMed

Insights

This study validates the Movement Disorder-Childhood Rating Scale (MD-CRS) for children with dyskinetic cerebral palsy (DCP). Patient and caregiver input confirmed the MD-CRS accurately reflects the impact of DCP on daily life.

Area of Science:

  • Neurology
  • Pediatrics
  • Clinical Outcome Assessment

Background:

  • Dyskinetic cerebral palsy (DCP) is a childhood-onset neurological disorder characterized by hyperkinetic movements and dystonia.
  • The Movement Disorder-Childhood Rating Scale (MD-CRS) assesses movement disorders in pediatric patients.
  • Establishing content validity of clinical outcome assessments is crucial for capturing patient perspectives.

Purpose of the Study:

  • To gather input from patients with DCP and their caregivers on the content validity of the MD-CRS.
  • To assess the relevance of MD-CRS items and response options from the patient and caregiver perspective.

Main Methods:

  • A qualitative, noninterventional, cross-sectional study involving interviews with children/adolescents (6-18 years) with DCP and their caregivers.
  • Participants described body regions and daily functions affected by DCP.
  • Caregivers reviewed MD-CRS Part I for item relevance and response option accuracy, with feedback analyzed using inductive content analysis.

Main Results:

  • Interviews with 8 patients and 12 caregivers confirmed MD-CRS items align with DCP-affected body regions and activities.
  • Involuntary movements associated with DCP were reported to interfere with motor, oral/verbal, and self-care activities.
  • Caregivers endorsed 12 of 15 MD-CRS Part I items, suggesting minor clarifications for others.

Conclusions:

  • Patient and caregiver input supports the content validity of the MD-CRS for children and adolescents with DCP.
  • The findings demonstrate that the MD-CRS is a relevant tool for assessing the impact of DCP in pediatric populations.
Abstract

Related Concept Videos